Rapid Influenza Diagnostic Tests Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2020-2024
Technavio has been monitoring the rapid influenza diagnostic tests market and it is expected to grow by USD 0.89 billion, decelerating at a CAGR of almost 11% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking View Free Sample Report
Rapid Influenza Diagnostic Tests Market: Key Trends to impact market growth
The rising government initiatives is one of the key rapid influenza diagnostic tests market market trends. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.
Rapid Influenza Diagnostic Tests Market: Top Drivers to Boost Demand
The rising demand for POCT is one of the primary factors driving the growth of the rapid influenza diagnostic tests market. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business
Vendor Analysis: Abbott Laboratories, Becton, Dickinson and Co. and bioMérieux SA are key growth contributors
The market is concentrated. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants.
For more insights on this market: Download a Free Sample Report
Rapid Influenza Diagnostic Tests Market: Key Highlights of the Report for 2020-2024
Rapid Influenza Diagnostic Tests Market Size to Grow by USD 0.89 billion through 2020-2024
Technavio research projects the rapid influenza diagnostic tests market to grow by USD 0.89 billion, decelerating at a CAGR of 11% till 2025. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking View Free Sample Report
Rapid Influenza Diagnostic Tests Market: Key Market Driver
One of the primary factors that will trigger the growth of the rapid influenza diagnostic tests market size is rising demand for POCT. This research report provides a comprehensive analysis of all the factors that are likely to propel market growth, taking into account the market trends as well as challenges that are likely to impede growth. The objective of this research report is to equip clients with actionable insights that will help them leverage opportunities and formulate growth strategies for their business.
Rapid Influenza Diagnostic Tests Market: Vendor Analysis
The market is concentrated due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio also offers custom research reports with detailed insights assessing the market from a global as well as regional perspective. This customized report will help clients keep up with new product launches in direct & indirect or related markets. It will also provide insights on upcoming developments along with a pipeline analysis of vendor operations and the impact of government regulations.
For more insights on this market: Download a Free Sample Report
Technavio has been monitoring the global rapid influenza diagnostic tests market and it is expected to grow by USD 0.89 billion decelerating at a CAGR of 11% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. View Free Sample Report
Rapid Influenza Diagnostic Tests Market: Segmentation by Product
RIDTs for influenza A segment accounted for the major share of the Rapid Influenza Diagnostic Tests Market owing to factors such as rising demand for POCT. The recent pandemic has also been a significant factor contributing to the growth of the influenza diagnostics market. This report provides an accurate prediction of the contribution of all the segments to the growth of the rapid influenza diagnostic tests market size.
Rapid Influenza Diagnostic Tests Market: Segmentation by Geography
North America will offer several growth opportunities to market vendors during the forecast period. The rising government initiatives will significantly influence rapid influenza diagnostic tests market's growth in this region. 34% of the market growth will originate from North America during the forecast period. The US is the key market for rapid influenza diagnostic tests market in North America. This report provides an accurate prediction of the contribution of all segments to the growth of the rapid influenza diagnostic tests market size.
Rapid Influenza Diagnostic Tests Market: Vendor Analysis
The market is concentrated. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Becton, Dickinson and Co. and bioMérieux SA are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio offers custom research reports with detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19 Download a Free Sample Report
